Fusion Pharmaceuticals Inc. Accounts Payable
Fusion Pharmaceuticals Inc. had Accounts Payable of $2.50 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-05-07
- 2024-03-31: Accounts Payable, Current $2.50M.
- 2023-12-31: Accounts Payable, Current $1.86M.
- 2023-09-30: Accounts Payable, Current $1.06M.
- 2023-06-30: Accounts Payable, Current $2.06M.
| Period end | Accounts Payable, Current |
|---|---|
| 2024-03-31 | $2.50M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.86M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $1.06M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.06M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.90M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.69M 10-K · filed 2024-03-20 |
| 2022-09-30 | $1.31M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.55M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.77M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.19M 10-K · filed 2023-03-16 |
| 2021-09-30 | $3.80M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $685.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.02M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $3.40M 10-K · filed 2022-03-17 |
| 2020-09-30 | $956.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $703.00K 10-Q · filed 2020-08-11 |
| 2019-12-31 | $830.00K 10-K · filed 2021-03-25 |